Horizon Therapeutics Public Limited Company - stock earnings
Stock symbol HZNP is outdated, potentially delisted? Maybe it is available on other exchange?
HZNP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | 54.7 million USD | 832.1 million USD |
| 2022Q4 | 120.4 million USD | 942.0 million USD |
| 2022Q3 | 135.8 million USD | 925.4 million USD |
| 2022Q2 | 61.0 million USD | 876.4 million USD |
| 2022Q1 | 204.3 million USD | 885.2 million USD |
| 2021Q4 | 173.2 million USD | 1.0 billion USD |
| 2021Q3 | 326.5 million USD | 1.0 billion USD |
| 2021Q2 | 158.1 million USD | 832.5 million USD |
| 2021Q1 | -123.4 million USD | 342.4 million USD |
| 2020Q4 | 190.6 million USD | 745.3 million USD |
| 2020Q3 | 292.8 million USD | 636.4 million USD |
HZNP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 521.5 million USD | 3.6 billion USD |
| 2021 | 534.5 million USD | 3.2 billion USD |
| 2020 | 389.8 million USD | 2.2 billion USD |
| 2019 | 573.0 million USD | 1.3 billion USD |
| 2018 | -38.4 million USD | 1.2 billion USD |
| 2017 | -350.1 million USD | 1.1 billion USD |
HZNP
Price: $116.30
52 week price:
Earnings Per Share: 5.66 USD
P/E Ratio: 61.86
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.6 million
Ebitda: 44.4 millionMarket Capitalization: 23.4 billion